Market Overview
According to DIResearch's in-depth investigation and research, the global Pharmaceutical CDMO market size will reach 167,817 Million USD in 2025 and is projected to reach 274,274 Million USD by 2032, with a CAGR of 7.27% (2025-2032). Notably, the China Pharmaceutical CDMO market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A Pharmaceutical Contract Development and Manufacturing Organization (CDMO) is a specialized service provider that offers comprehensive support to pharmaceutical and biotechnology companies in the development, manufacturing, and commercialization of drug products. CDMOs serve as strategic partners, providing expertise and infrastructure for various stages of the drug development process, including formulation development, analytical testing, clinical trial manufacturing, and commercial-scale production. These organizations play a crucial role in the pharmaceutical industry by offering flexible and cost-effective solutions, enabling companies to outsource specific aspects of their drug development and manufacturing processes. Pharmaceutical CDMOs contribute to accelerating time-to-market, reducing development costs, and ensuring compliance with regulatory standards, allowing pharmaceutical companies to focus on research, innovation, and core competencies.
The major global suppliers of Pharmaceutical CDMO include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics, AMRI, Famar, WuXi Biologics, Asymchem, Zhejiang Jiuzhou Pharmaceutical, Apeloa Pharmaceutical, Porton Pharma, Amatsigroup, Fujifilm Diosynth, Biotechnologies, PCI Pharma Services, Pfizer CentreOne, Samsung Biologics, AGC Biologics, Divi's Laboratories Ltd, Piramal Pharma Solutions, Syngene International Ltd, Aragen Life Sciences, Akums Drugs and Pharmaceuticals, IDT Australia, Mayne Pharma, BioCina, Southern RNA, PharmSky Research, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Pharmaceutical CDMO. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Pharmaceutical CDMO market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Pharmaceutical CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pharmaceutical CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Pharmaceutical CDMO Include:
Lonza
Catalent
Patheon (Thermo Fisher Scientific)
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics
AMRI
Famar
WuXi Biologics
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Apeloa Pharmaceutical
Porton Pharma
Amatsigroup
Fujifilm Diosynth
Biotechnologies
PCI Pharma Services
Pfizer CentreOne
Samsung Biologics
AGC Biologics
Divi's Laboratories Ltd
Piramal Pharma Solutions
Syngene International Ltd
Aragen Life Sciences
Akums Drugs and Pharmaceuticals
IDT Australia
Mayne Pharma
BioCina
Southern RNA
PharmSky Research
Pharmaceutical CDMO Product Segment Include:
Solid Formulation
Semi-solid Formulation
Liquid Formulation
Gas Formulation
Pharmaceutical CDMO Product Application Include:
Chemical Pharmaceutical
Biopharmaceutical
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Pharmaceutical CDMO Industry PESTEL Analysis
Chapter 3: Global Pharmaceutical CDMO Industry Porter's Five Forces Analysis
Chapter 4: Global Pharmaceutical CDMO Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Pharmaceutical CDMO Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Pharmaceutical CDMO Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Pharmaceutical CDMO Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook